Investigator Development Core

中大西洋心脏代谢健康公平中心（MACHE）将设立一名研究者， 发展（ID）核心有两个目标：（1）促进早期研究者的职业发展 建立以慢性病的健康差异为重点的研究事业;（2）提高 生物医学研究领域的劳动力。MACCHE包括The Johns之间的合作伙伴关系 霍普金斯大学（JHU）和马里兰州巴尔的摩大学（UMB）-这两所大学都有健康中心 公平和两者都是生物医学研究的卓越中心。为了实现其目标， Investigator Development Core确立了三个具体目标： 目标1。为博士后研究员，早期职业教师和其他早期阶段的学生建立一个试点项目计划。 研究人员支持与慢性病差异相关的创新研究。试点奖励计划将 从JHU、UMB、摩根州立大学、社区合作伙伴 以及周边的中大西洋地区，他们对解决慢性心脏代谢疾病感兴趣， 差距。MACCHE的试点计划将有意促进以下人员的试点申请： 在生物医学研究中代表性不足的群体，包括那些面临不利条件、残疾或 来自代表性不足的种族/民族群体。在研究申请经过同行评审后， 申请将根据同行评审的科学价值进行筛选， 由MACCHE指导委员会确定的战略考虑。 目标2。为试点项目获奖者创建多学科指导网络和社区（“MACCHE 卫生公平学者”），包括具有卫生公平专门知识的高级教员。在MACCHE ID的监督下 获得MACCHE试点奖的核心早期研究者将建立指导委员会，包括 一名主要导师和两名共同导师，在学者的背景学科中提供全面的职业指导。 在可能的情况下，我们将匹配学者与“国家”导师从另一个P50计划。在 此外，我们的核心计划教师顾问之一将监督学者在该计划的进展。 目标3。通过结构化的教学培训支持早期研究者，以促进道德，科学 严格的，可重复的研究，以解决慢性疾病的差异。试点补助金获得者将 要求参加关于“负责任的研究行为”和“科学严谨性和 在一个母机构提供的”生殖教育“。此外，还将鼓励他们参加 其他职业发展机会，包括赠款写作，学者技能和社区课程- 建立和编写责任小组。通过提供试点研究资金， 指导，MACCHE的试点奖励计划将促进创新的多学科慢性病 这将有助于缩小该地区的研究差距，并增强生物医学研究队伍的多样性。

The Mid-Atlantic Center for Cardiometabolic Health Equity (MACCHE) will establish an Investigator Development (ID) Core with two objectives: (1) to promote career development for Early-Stage Investigators establishing research careers focused on health disparities for chronic diseases; and (2) enhancing diversity of the workforce in this area of biomedical research. MACCHE includes a partnership between The Johns Hopkins University (JHU) and University of Maryland Baltimore (UMB) – both of which have Centers for Health Equity and both of which are centers of excellence for biomedical research. To accomplish its objectives, the Investigator Development Core has established three specific aims: Aim #1. To establish a pilot project program for postdoctoral fellows, early career faculty and other Early-Stage Investigators to support innovative research related to chronic disease disparities. The pilot award program will solicit applications from early-stage investigators at JHU, UMB, Morgan State University, community partners, and the surrounding Mid-Atlantic region who have an interest in addressing chronic, cardiometabolic disease disparities. MACCHE's pilot program will work deliberately to promote pilot applications from persons from underrepresented groups in biomedical research, including those who have faced disadvantage, disability, or come from an under-represented racial/ethnic group. After research applications undergo peer review, applications will be selected for funding based on scientific merit as assessed by peer review in combination with strategic considerations as determined by MACCHE's Steering Committee. Aim #2. To create a multidisciplinary mentoring network and community for pilot project awardees (“MACCHE health equity scholars”) inclusive of senior faculty with health equity expertise. With oversight by MACCHE's ID Core, Early-Stage Investigators receiving MACCHE pilot awards will establish mentoring committees including a primary mentor and two co-mentors to provide overall career mentoring in scholar's background discipline. When possible, we will match scholars with a `national' mentor from another one of the P50 programs. In addition, one of our Core program faculty advisors will oversee the scholar's progress in the program. Aim #3. To support Early-Stage Investigators with structured didactic training to promote ethical, scientifically rigorous, and reproducible research to address chronic disease disparities. Pilot grant awardees will be required to participate in didactic training on “Responsible Conduct of Research” and “Scientific Rigor and Reproducibility” offered at one of the parent institutions. In addition, they will be encouraged to participate in other career development opportunities, including courses on Grant Writing, Scholar Skills and Community- Building, and Writing Accountability Groups. By providing pilot research funding in combination with enhanced mentoring, MACCHE's Pilot Award Program will promote innovative multi-disciplinary chronic disease disparities research in the region and also enhance the diversity of the biomedical research workforce.